Merkel cell carcinoma of the head and neck: emphasizing the risk of undertreatment

  title={Merkel cell carcinoma of the head and neck: emphasizing the risk of undertreatment},
  author={Ferdinand C. A. Timmer and Willem Martin C Klop and Germaine N. Relyveld and Marianne B. Crijns and Alfons J. M. Balm and Michiel W. M. van den Brekel and Peter J. F. M. Lohuis},
  journal={European Archives of Oto-Rhino-Laryngology},
Merkel cell carcinoma (MCC) is a rare primary cutaneous neuroendocrine carcinoma. It occurs predominantly in the head and neck area and often behaves aggressively. In this single-institution retrospective observational cohort study, we describe the results of a treatment strategy that we developed over the past decades. Endpoints of this study were local, regional and distant control, disease-specific survival and overall survival. In total 47 patients with head and neck MCC, diagnosed in the… CONTINUE READING


Publications referenced by this paper.
Showing 1-10 of 28 references

case series and literature review of 1024 cases

  • H Medina-Franco, MM Urist, J Fiveash, MJ Heslin, KI Bland, carcinoma Beenken SW Multimodality treatment of Merkel cell
  • Ann Surg Oncol 8:204–208 Eur Arch…
  • 2016

the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy

  • RE Warner, MJ Quinn, G Hruby, RA Scolyer, RF Uren, carcinoma Thompson JF Management of merkel cell
  • Ann Surg Oncol 15:2509–2518 1250 Eur Arch…
  • 2016
2 Excerpts

Similar Papers

Loading similar papers…